Skip to content

The expression level and clinical significance of claudin-5 in patients with acute pancreatitis

The expression level and clinical significance of claudin-5 in patients with acute pancreatitis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061440
Enrollment
Unknown
Registered
2022-06-25
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Sponsors

Subei People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-70 years. 2. Meet the basic diagnostic criteria for acute pancreatitis. 3. Newly diagnosed patients in our hospital. 4. Informed consent of the patient.

Exclusion criteria

Exclusion criteria: 1. Patients with acute attack of stroke, heart failure or chronic pancreatitis; 2. Patients who have been treated in other hospitals before admission.

Design outcomes

Primary

MeasureTime frame
Claudin-5;

Countries

China

Contacts

Public ContactGeng Ping
18051061912@yzu.edu.cn+86 18051061912

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026